Protocol: 30 individuals underwent a dermatologist-applied acid peel. Following the peel, panelists were randomly assigned a placebo base to one side of the face and the BarrierRepairPRO™ formula to the other side of the face. Efficacy was blindly assessed by the investigator 48 hours after the peel and two weeks after the peel.
Acid Peel Clinical Results
DermCeutical Barrier RepairPRO™ scavenges free radicals, protecting skin from damage caused by environmental aggressors.
DermCeutical Barrier RepairPRO™ inhibits elastase activity, helping to maintain integrity of skin’s extracellular matrix and prevent the appearance of aged skin.
DermCeutical Barrier RepairPRO™ helps to inhibit glycation, contributing to maintenance of skin’s extracellular matrix.
Wound Closure Rate
METHOD:
SUMMARY:
DermCeutical Barrier RepairPRO™ increases fibroblast migration at a rate greater than ascorbic acid. At 0.3% topical equivalent DermCeutical Barrier RepairPRO™ supports mechanisms of cellular repair.
Epidermal Barrier Repair
METHOD:
SUMMARY:
DermCeutical Barrier RepairPRO™ increases loricrin and filaggrin expression. At 0.3% topical equivalent DermCeutical Barrier RepairPRO™ supports mechanisms of skin barrier support.
Skin Soothing
METHOD:
SUMMARY:
DermCeutical Barrier RepairPRO™ decreases IL-6 concentration in stressed cells. At 0.3% topical equivalent DermCeutical Barrier RepairPRO™ supports anti-inflammatory mechanisms.
Anti-aging
METHOD:
SUMMARY:
DermCeutical Barrier RepairPRO™ increases elastin production at a rate similar to ascorbic acid. At 0.3% topical equivalent DermCeutical Barrier RepairPRO™ supports mechanisms of anti-aging.